CORR Insights®: Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.
作者信息
Damron Timothy A
机构信息
T. A. Damron, Vice-Chairman and David G. Murray Professor, Department of Orthopedic Surgery, Upstate Medical University, Upstate Bone and Joint Center, East Syracuse, NY, USA.
出版信息
Clin Orthop Relat Res. 2020 May;478(5):1086-1088. doi: 10.1097/CORR.0000000000001217.
Abstract
摘要
相似文献
1
CORR Insights®: Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.CORR 见解®：刮除术治疗骨巨细胞瘤患者中，地诺单抗治疗与局部复发有关联吗？一项系统评价。
Clin Orthop Relat Res. 2020 May;478(5):1086-1088. doi: 10.1097/CORR.0000000000001217.
2
Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.骨巨细胞瘤患者经刮除术后应用地舒单抗治疗是否与局部复发相关？一项系统性评价。
Clin Orthop Relat Res. 2020 May;478(5):1076-1085. doi: 10.1097/CORR.0000000000001074.
3
Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.术前 denosumab 治疗联合刮除术可能是骨巨细胞瘤复发的一个危险因素。
J Orthop Surg (Hong Kong). 2020 Jan-Apr;28(2):2309499020929786. doi: 10.1177/2309499020929786.
4
The role of Denosumab in joint preservation for patients with giant cell tumour of bone.地诺单抗在骨巨细胞瘤患者关节保留中的作用。
Bone Joint J. 2021 Jan;103-B(1):184-191. doi: 10.1302/0301-620X.103B1.BJJ-2020-0274.R1.
5
Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab.骨巨细胞瘤新辅助地舒单抗治疗后局部复发的评估。
Clin Orthop Surg. 2019 Sep;11(3):352-360. doi: 10.4055/cios.2019.11.3.352. Epub 2019 Aug 12.
6
Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.日本保肢术或不保肢术刮除术后骨巨细胞瘤的临床疗效：来自 JCOG1610 研究的问卷调查。
World J Surg Oncol. 2018 Aug 8;16(1):160. doi: 10.1186/s12957-018-1459-6.
7
Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage.地舒单抗可能增加骨巨细胞瘤患者经刮除治疗后的局部复发风险。
J Bone Joint Surg Am. 2018 Mar 21;100(6):496-504. doi: 10.2106/JBJS.17.00057.
8
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.地诺单抗与手术联合治疗骨巨细胞瘤的风险与益处——病例系列研究
World J Surg Oncol. 2016 Nov 4;14(1):281. doi: 10.1186/s12957-016-1034-y.
9
Preoperative Denosumab Therapy Against Giant Cell Tumor of Bone is Associated with an Increased Risk of Local Recurrence After Curettage Surgery.术前地舒单抗治疗骨巨细胞瘤与刮除术后局部复发风险增加相关。
Ann Surg Oncol. 2022 Jun;29(6):3992-4000. doi: 10.1245/s10434-022-11411-9. Epub 2022 Feb 17.
10
ASO Author Reflections: Preoperative Denosumab May Increase the Risk of Local Recurrence of Giant Cell Tumor of Bone after Curettage Surgery.美国骨科学会作者反思：术前使用地诺单抗可能会增加刮除术后骨巨细胞瘤局部复发的风险。
Ann Surg Oncol. 2022 Jun;29(6):4001. doi: 10.1245/s10434-022-11430-6. Epub 2022 Feb 15.
本文引用的文献
1
Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.骨巨细胞瘤患者经刮除术后应用地舒单抗治疗是否与局部复发相关？一项系统性评价。
Clin Orthop Relat Res. 2020 May;478(5):1076-1085. doi: 10.1097/CORR.0000000000001074.
2
Present day controversies and consensus in curettage for giant cell tumor of bone.当今骨巨细胞瘤刮除术的争议与共识
J Clin Orthop Trauma. 2019 Nov-Dec;10(6):1015-1020. doi: 10.1016/j.jcot.2019.09.017. Epub 2019 Oct 11.
3
Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.分子靶向治疗时代之前肢体复发性骨巨细胞瘤的临床结局：日本肌肉骨骼肿瘤学组研究
BMC Musculoskelet Disord. 2016 Jul 22;17:306. doi: 10.1186/s12891-016-1163-z.
4
Moving forward through consensus: protocol for a modified Delphi approach to determine the top research priorities in the field of orthopaedic oncology.通过共识推进：一种改进的德尔菲法协议，用于确定骨肿瘤学领域的首要研究重点
BMJ Open. 2016 May 24;6(5):e011780. doi: 10.1136/bmjopen-2016-011780.
5
Management of spinal giant cell tumors.脊柱巨细胞瘤的管理
Spine J. 2016 Feb;16(2):259-69. doi: 10.1016/j.spinee.2015.10.045. Epub 2015 Oct 30.
6
Giant cell tumors of the sacrum--a nationwide study on midterm results in 26 patients after intralesional excision.骶骨巨细胞瘤——一项关于26例患者经病灶内切除术后中期结果的全国性研究。
Eur Spine J. 2014 Sep;23(9):1949-62. doi: 10.1007/s00586-014-3263-5. Epub 2014 Mar 11.
7
Recurrence of giant-cell tumors of the long bones after curettage and packing with cement.长骨巨细胞瘤刮除并骨水泥填充后的复发情况
J Bone Joint Surg Am. 1994 Dec;76(12):1827-33. doi: 10.2106/00004623-199412000-00009.
8
Benign giant-cell tumor of bone with pulmonary metastases: clinical findings and radiologic appearance of metastases in 13 cases.骨良性巨细胞瘤伴肺转移：13例转移灶的临床及影像学表现
AJR Am J Roentgenol. 1992 Feb;158(2):331-4. doi: 10.2214/ajr.158.2.1729794.
Zotero 插件